Starling Oncology, Inc.
STLN· Nasdaq
STLNStarling Oncology, Inc.
Quarterly figures for Starling Oncology, Inc., with source filings when available.
27 quarters. Dec 31, 2019 to Jun 30, 2026. USD.
Starling Oncology, Inc. has filed its 10-Q within 37 to 44 days of period end across its last 8 quarters. The 10-K runs 70 to 89 days.
Starling Oncology, Inc. · CIK 1799191 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $161.28M | +34.6% | -$0.08 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 7, 2026 · after-hours |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $147.44M |
| +41.2% |
| -$0.02 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 12, 2026 · after-hours | Mar 12, 2026 | 71 d | 10-K | $141.96M | +41.6% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · after-hours | Nov 13, 2025 | 44 d | 10-Q | $136.56M | +36.7% | -$0.14 | |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 · after-hours | Aug 13, 2025 | 44 d | 10-Q | $119.80M | +21.5% | -$0.15 | |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 · after-hours | May 14, 2025 | 44 d | 10-Q | $104.41M | +10.3% | -$0.21 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024 | Dec 31, 2024 | Mar 24, 2025 · pre-market | Mar 26, 2025 | 85 d | 10-K | $100.27M | +16.9% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | $99.90M | +21.8% | -$0.18 | |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 · after-hours | Aug 13, 2024 | 44 d | 10-Q | $98.58M | +22.9% | -$0.17 | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · after-hours | May 14, 2024 | 44 d | 10-Q | $94.67M | +24.2% | -$0.22 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 27, 2024 · after-hours | Mar 28, 2024 | 88 d | 10-K | $85.79M | +20.1% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 · after-hours | Nov 8, 2023 | 39 d | 10-Q | $82.04M | +26.3% | -$0.19 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 9, 2023 | 40 d | 10-Q | $80.22M | +31.7% | -$0.19 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · after-hours | May 10, 2023 | 40 d | 10-Q | $76.19M | +38.1% | -$0.33 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 16, 2023 · after-hours | Mar 16, 2023 | 75 d | 10-K | $71.42M | +36.6% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · after-hours | Nov 9, 2022 | 40 d | 10-Q | $64.98M | +24.3% | -$0.17 | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $60.92M | +22.2% | -$0.06 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | $55.16M | +13.5% | $0.21 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 10, 2022 · after-hours | Mar 11, 2022 | 70 d | 10-K | $52.30M | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 8, 2021 | 39 d | 10-Q | $52.28M | — | -$0.05 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | $49.84M | — | $0.05 | |
| Q1 2021 | Mar 31, 2021 | — | May 28, 2021 | 58 d | 10-Q | $48.58M | — | -$0.02 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 30, 2021 | 89 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 13, 2020 | 44 d | 10-Q | — | — | — | |
| Q2 2020 | Jun 30, 2020 | — | Aug 13, 2020 | 44 d | 10-Q | — | — | — | |
| Q1 2020 | Mar 31, 2020 | — | May 8, 2020 | 38 d | 10-Q | — | — | — | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | — | — | — | — | — | — | |
